| Sep 9, 2014
| 5:05 PM
BOSTON (Reuters) - After months of staying largely silent on a deal he is trying to broker, billionaire William Ackman on Tuesday criticized Allergan Inc 's board of directors, urging them to "wake up" and at least listen to what potential purchaser...
| Jul 22, 2014
Botox maker Allergan Inc. said Monday that it will cut 1,500 employees, most of them in Southern California, in a cost-cutting effort the Irvine company hopes will help it fight off a hostile takeover bid by a Canadian rival.
Stung by criticism that it'...
| Jul 22, 2014
| 5:03 PM
Feelings were mixed among Allergan Inc. employees one day after the Botox maker announced 1,500 job cuts, mostly in Southern California.
Outside of Allergan’s Irvine campus, where the bulk of the 650 research and development jobs the company...
| Jul 21, 2014
| 12:59 PM
Most of the 1,500 job cuts that Botox maker Allergan Inc. announced Monday morning will be made in Southern California, the company’s chief executive said.
Allergan plans to eliminate 650 research and development jobs, the bulk of them at its...
| Jun 19, 2014
| 4:54 PM
Wall Street sharks are not the only ones keeping a close watch on the contentious battle for control of Allergan Inc., the Irvine company that makes Botox. So are thousands of the company's scientists and researchers, many of whose jobs may be at risk....
| Jun 23, 2014
| 11:53 AM
Allergan Inc., the Irvine company that makes Botox, is urging shareholders to reject a buyout offer from a Canadian pharmaceutical firm.
Valeant Pharmaceuticals International Inc. has offered to buy all of Allergan’s shares for a combination of...
| May 12, 2014
| 9:59 AM
Botox-maker Allergan Inc. said it rejected a takeover bid from Valeant Pharmaceuticals International Inc., a deal the company said undervalued its worth and posed significant risks to shareholders.
Last month, the Irvine drugmaker received an...
| May 12, 2014
| 7:51 PM
Botox maker Allergan Inc. rejected a $46-billion takeover offer from a Canadian rival, setting the stage for what analysts said may become a long and nasty fight for control of the Irvine company and its prized collection of eye and skin medications....
| May 13, 2014
| 7:41 AM
The stakes for Botox maker Allergan Inc. just got higher.
Valeant Pharmaceutical International Inc. said it intends to raise its bid for Allergan, one day after the Irvine company defiantly rejected its initial offer as too low.
In a letter to...
| May 28, 2014
| 5:37 PM
For weeks, Valeant Pharmaceuticals had promised a better offer for Botox maker Allergan, but its renewed cash-and-stock offer fell flat with investors and analysts.
After Irvine-based Allergan Inc. rejected a $46-billion offer earlier this month, the...
| Jun 10, 2014
| 12:02 PM
The board of Botox maker Allergan Inc. unanimously rejected an increased buyout offer from a Canadian pharmaceutical company as the closely watched acquisition effort showed no signs of a resolution.
Valeant Pharmaceuticals International Inc. last month...